所有图片(1)
别名:
ENA-713, N-乙基 -甲基-全氟酸 3-[(1S)-1-(二甲基氨基)乙基] 苯酯 酒石酸酯, 乙基甲基氨基甲酸 3-[(1S)-1-(二甲基氨基)乙基]苯基酯, 酒石酸卡巴拉汀 酒石酸酯
经验公式（希尔记法）:
C14H22N2O2 · C4H6O6
推荐产品
等级
pharmaceutical primary standard
形式
solid
保质期
limited shelf life, expiry date on the label
制造商/商品名称
BP
应用
pharmaceutical
pharmaceutical small molecule
格式
neat
储存温度
2-8°C
InChI
1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1
InChI key
GWHQHAUAXRMMOT-RWALOXMOSA-N
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Rivastigmine hydrogen tartrate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.
Also used in monographs such as:Rivastigmine Transdermal Patches Rivastigmine Capsules Rivastigmine Oral Solution
Also used in monographs such as:
生化/生理作用
卡巴拉汀是一种口服口服、脑透过性、可逆的胆碱酯酶抑制剂，可增强阿尔茨海默症和帕金森氏病患者的认知功能。卡巴拉汀可同时抑制丁酰胆碱酯酶和乙酰胆碱酯酶。
包装
Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
警示用语：
Danger
危险声明
危险分类
Acute Tox. 2 Oral - Aquatic Chronic 2
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门